Best SellerPre-loaded PT-141 (Bremelanotide) research pen. Investigated for its activity at central melanocortin receptors.
Purity
99%+
CAS Number
189691-06-3
Status
In Stock
Dispatch
Same-Day (before 2pm)
Select Size
£149.99
Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.
PT-141, also known as Bremelanotide, is a synthetic cyclic-peptide melanocortin-receptor agonist studied for its activity at MC3-R and MC4-R in central nervous system research models. Unlike vasoactive compounds that act on peripheral blood flow, PT-141 has been investigated for centrally mediated pathways relevant to arousal and behavioural research. Supplied as a pre-loaded research pen for in-vitro and preclinical applications.
A simplified summary of what PT-141 Pen is studied for in research models. For laboratory in-vitro use only.
Sequence:Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Origin: Synthetic cyclic heptapeptide analogue of α-MSH, derived from the Melanotan II scaffold and produced by solid-phase peptide synthesis.
A cyclic melanocortin-receptor agonist investigated for its binding affinity to central nervous system melanocortin receptors in research models.
Preclinical studies have explored downstream effects on Gαs-coupled cAMP signalling, central neurotransmitter release, and autonomic-response markers in animal research.
Used as a research tool in laboratory models exploring melanocortin neurobiology, central-nervous-system pharmacology, and behavioural-response research. Not approved for human use.
For research use only. PT-141 Pen is not approved as a medicine in the UK and is not intended for human or veterinary administration. See the compliance page for full terms.
| Compound Name | PT-141 Pen |
| Category | Sexual Health |
| CAS Number | 189691-06-3 |
| Molecular Weight | 1025.18 g/mol |
| Molecular Formula | C₅₀H₆₈N₁₄O₁₀ |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Purity | ≥99%+ (HPLC) |
| Form | Lyophilised powder |
| Storage | Store at 2–8°C. Protect from light. Use within 30 days of opening. |
| Reconstitution | Pre-formulated in solution; no reconstitution required. |
Every order of PT-141 Pen includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.
PT-141 (Bremelanotide) is a synthetic cyclic peptide investigated as a melanocortin-receptor agonist in central nervous system research.
99%+, confirmed by independent third-party HPLC analysis. Batch-specific CoA included.
No. Supplied for in-vitro laboratory research only. PT-141 is still experimental and not recommended for human consumption.
PT-141 Pen is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.